ProCE Banner Activity

Understanding BCL-2 Inhibitor Treatment and Management of Potential Side Effects


Downloadable patient resource for healthcare professionals to use when discussing venetoclax therapy for acute myeloid leukemia or chronic lymphocytic leukemia/small lymphocytic lymphoma, including side effect management.

Released: May 20, 2024

Expiration: May 19, 2025



Caitlin R. Rausch

Caitlin R. Rausch, PharmD, BCOP

Clinical Pharmacy Specialist, Leukemia
MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from AbbVie Inc.

AbbVie Inc.